We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Hepatocellular carcinoma, vascular endothelial growth factor receptors‐targeting agents, and hypertension: A much more complicated relationship than expected.
- Authors
Porta, Camillo; Negri, Francesca; Cosmai, Laura
- Abstract
Hepatocellular carcinoma (HCC) relationship with hypertension is a complicated phenomenon, mainly depending on the causes of the primary liver disease and the potential for drug interactions between concomitant medications and vascular endothelial growth factor receptor inhibitors. Another interesting point worth exploring is how to treat hypertension in HCC patients under anticancer multikinase inhibitor therapy and the possible impact of certain antihypertensive agents on patients' outcome.
- Subjects
VASCULAR endothelial growth factors; VASCULAR endothelial growth factor receptors; VASCULAR endothelial growth factor antagonists; HEPATOCELLULAR carcinoma; ANTIHYPERTENSIVE agents
- Publication
Cancer (0008543X), 2024, Vol 130, Issue 8, p1208
- ISSN
0008-543X
- Publication type
Article
- DOI
10.1002/cncr.35218